Comerica Bank’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$296K Sell
1,435
-13
-0.9% -$2.6K ﹤0.01% 2117
2025
Q3
$260K Buy
1,448
+109
+8% +$18.6K ﹤0.01% 2218
2025
Q2
$216K Buy
1,339
+54
+4% +$8.6K ﹤0.01% 2282
2025
Q1
$219K Sell
1,285
-1,158
-47% -$201K ﹤0.01% 2251
2024
Q4
$406K Sell
2,443
-770
-24% -$132K ﹤0.01% 1980
2024
Q3
$552K Sell
3,213
-25
-0.8% -$4.14K ﹤0.01% 1839
2024
Q2
$499K Sell
3,238
-1,508
-32% -$226K ﹤0.01% 1848
2024
Q1
$730K Sell
4,746
-189
-4% -$28.8K ﹤0.01% 1701
2023
Q4
$780K Sell
4,935
-842
-15% -$121K ﹤0.01% 1650
2023
Q3
$845K Buy
+5,777
New +$880K ﹤0.01% 1530
2020
Q3
Sell
-1,148
Closed -$201K 2299
2020
Q2
$201K Buy
+1,148
New +$180K ﹤0.01% 2153
2013
Q4
Sell
-4,189
Closed -$272K 2344
2013
Q3
$272K Buy
+4,189
New +$265K ﹤0.01% 2283

Other funds holding FBT

Comerica Bank's FBT Position: Q4 2025 in Review

Comerica Bank reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 0.9% in Q4 2025, selling an estimated $2.6K and leaving 1,435 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #2117.

Comerica Bank first reported a position in FBT in Q3 2013 and has held it in 12 quarters since. The position peaked at $845K in Q3 2023. 279 funds tracked by Wall St. Rank hold FBT as of Q4 2025.

  • Comerica Bank held 1,435 shares of First Trust NYSE Arca Biotechnology Index Fund worth $296K as of Q4 2025.
  • Comerica Bank sold 13 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2025, an estimated $2.6K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2117 holding.
  • Comerica Bank first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2013 and has held it in 12 quarters since.
  • Comerica Bank's First Trust NYSE Arca Biotechnology Index Fund position peaked at $845K in Q3 2023.
  • 279 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.